CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading compound profile…

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Cannabinoids/6A,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-propyl-6H-dibenzo(b,d)pyran-1-ol

Other compounds reported in Cannabis

6A,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-propyl-6H-dibenzo(b,d)pyran-1-ol

6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-propyl-6H-dibenzo(b,d)pyran-1-oltetrahydrocannabivarin

42public articles

3registered condition areas

All documents →

Identity & provenance

Chemical identity

C19H26O2 · molecular weight 286.4

CAS: 28172-17-0↗INCHI: InChI=1S/C19H26O2/c1-5-6-13-10-16(20)18-14-9-12(2)7-8-15(14)19(3,4)21-17(18)11-13/h9-11,14-15,20H,5-8H2,1-4H3↗INCHIKEY: ZROLHBHDLIHEMS-UHFFFAOYSA-N↗PUBCHEM_CID: 34180↗WIKIDATA: Q254768↗

Sources: LOTUS / Wikidata · wikidata-9c807e0fdee72916 PubChem computed properties · pug-564dbaff6d80eb88

1 referenced plant-occurrence records. They are identity candidates, not clinical evidence.

Research areas

Conditions found alongside this compound

Document links and organism occurrence are candidates, not proof of efficacy, safety or a treatment recommendation.

Epilepsy and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Chronic pain and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Parkinson disease and cannabinoids

1 matching public articles

Candidate association · not a treatment claim

Linked local records

Medicines and registered studies

Links use source-reported active ingredients or study intervention names and remain candidates, not treatment claims.

Medicines with this active ingredient

No public medicine record matched.

Registered studies

5 exact source-intervention matches.

Protocol onlyNOT_YET_RECRUITING

Development of Tetrahydrocannabivarin as a Treatment for Smokers

Δ9-Tetrahydrocannabivarin (oral gummy)

Protocol onlyCOMPLETED

A Randomised, Double Blind, Placebo Controlled, Parallel Group, Dose Ranging Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes

GWP42004

Results postedCOMPLETED

A Randomised, Double Blind, Placebo Controlled, Parallel Group, Pilot Study of 1:1 and 20:1 Ratio of Formulated GWP42003 : GWP42004 Plus GWP42003 and GWP42004 Alone in the Treatment of Dyslipidaemia in Subjects With Type 2 Diabetes

GWP42004

Protocol onlyCOMPLETED

Weight Loss and Therapeutic Metablic Effects of Tetrahydrocannabivarin (THCV) Impregnated Mucoadhesive Strips

Tetrahydrocannabivarin

Protocol onlyUNKNOWN

Androgenetic Alopecia Treatment Using Varin and Cannabidiol-rich Topical Hemp Oil - A Case Series

Hemp Oil

Latest documents

Recent research

2026

Integrative network analysis reveals organizational principles of the endocannabinoid system.

Journal of Cannabis Research · Free full text

2026

Temperature-dependent gating pathways in TRPV3.

Scientific Reports · Free full text

2026

Natural Hydrophobic Deep Eutectic Solvent-Based Enhanced Extraction of Bioactive Compounds from Cannabis sativa L. Leaf for Pharmaceutical Applications.

International Journal of Molecular Sciences · Free full text

2025

Phytocannabinoids as Novel SGLT2 Modulators for Renal Glucose Reabsorption in Type 2 Diabetes Management.

Pharmaceuticals · Free full text

2025

Ligand-induced cold activation of TRPV3

Research Square · Free full text

2025

The role of tetrahydrocannabivarin (THCV) in metabolic disorders: A promising cannabinoid for diabetes and weight management.

AIMS Neuroscience · Free full text

2025

Application of thermogravimetric analysis (TGA) and differential scanning calorimetry (DSC) to estimate the normal boiling points of ∆9-tetrahydrocannabivarin (THCV) and ∆9-tetrahydrocannabinol (THC).

Journal of Cannabis Research · Free full text

Ontology definitions normalize terms; they do not establish medical claims.

2025

Tetrahydrocannabivarin (THCV) Dose Dependently Blocks or Substitutes for Tetrahydrocannabinol (THC) in a Drug Discrimination Task in Rats.

Biomolecules · Free full text

2025-08-10

Cannabivarin and Tetrahydrocannabivarin Modulate Nociception via Vanilloid Channels and Cannabinoid-Like Receptors in Caenorhabditis elegans

bioRxiv · Free full text · non-commercial reuse

2024

Select Minor Cannabinoids from Cannabis sativa Are Cannabimimetic and Antinociceptive in a Mouse Model of Chronic Neuropathic Pain.

The Journal of Pharmacology and Experimental Therapeutics · Free full text · non-commercial reuse

2024

Using In Silico Molecular Docking to Explain Differences in Receptor Binding Behavior of HHC and THCV Isomers: Revealing New Binding Modes.

Pharmaceuticals · Free full text

2024

Ultrafast, Selective, and Highly Sensitive Nonchromatographic Analysis of Fourteen Cannabinoids in Cannabis Extracts, Δ8-Tetrahydrocannabinol Synthetic Mixtures, and Edibles by Cyclic Ion Mobility Spectrometry-Mass Spectrometry.

Analytical Chemistry · Free full text